1
|
Viant MR, Amstalden E, Athersuch T, Bouhifd M, Camuzeaux S, Crizer DM, Driemert P, Ebbels T, Ekman D, Flick B, Giri V, Gómez-Romero M, Haake V, Herold M, Kende A, Lai F, Leonards PEG, Lim PP, Lloyd GR, Mosley J, Namini C, Rice JR, Romano S, Sands C, Smith MJ, Sobanski T, Southam AD, Swindale L, van Ravenzwaay B, Walk T, Weber RJM, Zickgraf FM, Kamp H. Demonstrating the reliability of in vivo metabolomics based chemical grouping: towards best practice. Arch Toxicol 2024; 98:1111-1123. [PMID: 38368582 PMCID: PMC10944399 DOI: 10.1007/s00204-024-03680-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2023] [Accepted: 01/15/2024] [Indexed: 02/19/2024]
Abstract
While grouping/read-across is widely used to fill data gaps, chemical registration dossiers are often rejected due to weak category justifications based on structural similarity only. Metabolomics provides a route to robust chemical categories via evidence of shared molecular effects across source and target substances. To gain international acceptance, this approach must demonstrate high reliability, and best-practice guidance is required. The MetAbolomics ring Trial for CHemical groupING (MATCHING), comprising six industrial, government and academic ring-trial partners, evaluated inter-laboratory reproducibility and worked towards best-practice. An independent team selected eight substances (WY-14643, 4-chloro-3-nitroaniline, 17α-methyl-testosterone, trenbolone, aniline, dichlorprop-p, 2-chloroaniline, fenofibrate); ring-trial partners were blinded to their identities and modes-of-action. Plasma samples were derived from 28-day rat tests (two doses per substance), aliquoted, and distributed to partners. Each partner applied their preferred liquid chromatography-mass spectrometry (LC-MS) metabolomics workflows to acquire, process, quality assess, statistically analyze and report their grouping results to the European Chemicals Agency, to ensure the blinding conditions of the ring trial. Five of six partners, whose metabolomics datasets passed quality control, correctly identified the grouping of eight test substances into three categories, for both male and female rats. Strikingly, this was achieved even though a range of metabolomics approaches were used. Through assessing intrastudy quality-control samples, the sixth partner observed high technical variation and was unable to group the substances. By comparing workflows, we conclude that some heterogeneity in metabolomics methods is not detrimental to consistent grouping, and that assessing data quality prior to grouping is essential. We recommend development of international guidance for quality-control acceptance criteria. This study demonstrates the reliability of metabolomics for chemical grouping and works towards best-practice.
Collapse
Affiliation(s)
- Mark R Viant
- Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
| | - E Amstalden
- Amsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands
| | - T Athersuch
- Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK
| | - M Bouhifd
- European Chemicals Agency, Telakkakatu 6, FI-00121, Helsinki, Finland
| | - S Camuzeaux
- Department of Metabolism, Digestion and Reproduction, National Phenome Centre, Imperial College London, London, W12 0NN, UK
| | - D M Crizer
- Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27709, USA
| | - P Driemert
- BASF Metabolome Solutions GmbH, Tegeler Weg 33, 10589, Berlin, Germany
| | - T Ebbels
- Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK
| | - D Ekman
- Center for Environmental Measurement and Modeling, Environmental Protection Agency, Athens, GA, 30605, USA
| | - B Flick
- BASF SE, Carl-Bosch-Str 38, 67056, Ludwigshafen, Germany
- NUVISAN ICB GmbH, Toxicology, 13353, Berlin, Germany
| | - V Giri
- BASF SE, Carl-Bosch-Str 38, 67056, Ludwigshafen, Germany
| | - M Gómez-Romero
- Department of Metabolism, Digestion and Reproduction, National Phenome Centre, Imperial College London, London, W12 0NN, UK
| | - V Haake
- BASF Metabolome Solutions GmbH, Tegeler Weg 33, 10589, Berlin, Germany
| | - M Herold
- BASF Metabolome Solutions GmbH, Tegeler Weg 33, 10589, Berlin, Germany
| | - A Kende
- Syngenta, Jealott's Hill International Research Centre, Bracknell, RG42 6EY, UK
| | - F Lai
- Syngenta, Jealott's Hill International Research Centre, Bracknell, RG42 6EY, UK
| | - P E G Leonards
- Amsterdam Institute for Life and Environment (A-LIFE), Vrije Universiteit Amsterdam, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands
| | - P P Lim
- Syngenta, Jealott's Hill International Research Centre, Bracknell, RG42 6EY, UK
| | - G R Lloyd
- Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
| | - J Mosley
- Center for Environmental Measurement and Modeling, Environmental Protection Agency, Athens, GA, 30605, USA
| | - C Namini
- Center for Environmental Measurement and Modeling, Environmental Protection Agency, Athens, GA, 30605, USA
| | - J R Rice
- Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27709, USA
| | - S Romano
- Center for Environmental Measurement and Modeling, Environmental Protection Agency, Athens, GA, 30605, USA
| | - C Sands
- Department of Metabolism, Digestion and Reproduction, National Phenome Centre, Imperial College London, London, W12 0NN, UK
| | - M J Smith
- Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
| | - T Sobanski
- European Chemicals Agency, Telakkakatu 6, FI-00121, Helsinki, Finland
| | - A D Southam
- Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
| | - L Swindale
- Syngenta, Jealott's Hill International Research Centre, Bracknell, RG42 6EY, UK
| | - B van Ravenzwaay
- BASF SE, Carl-Bosch-Str 38, 67056, Ludwigshafen, Germany
- Environmental Sciences Consulting, 67122, Altrip, Germany
| | - T Walk
- BASF Metabolome Solutions GmbH, Tegeler Weg 33, 10589, Berlin, Germany
| | - R J M Weber
- Phenome Centre Birmingham, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
| | - F M Zickgraf
- BASF SE, Carl-Bosch-Str 38, 67056, Ludwigshafen, Germany
| | - H Kamp
- BASF Metabolome Solutions GmbH, Tegeler Weg 33, 10589, Berlin, Germany
| |
Collapse
|
2
|
Csulak T, Hajnal A, Kiss S, Dembrovszky F, Sipos Z, Varjú-Solymár M, Kovács M, Herold M, Varga E, Hegyi P, Tényi T, Herold R. A systematic review and meta-analysis of implicit Theory of Mind in schizophrenia. Eur Psychiatry 2022. [PMCID: PMC9567008 DOI: 10.1192/j.eurpsy.2022.319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction Everyday social interactions are based on Theory of Mind (ToM) or mentalizing, whose complex processes are involved in understanding, representing one’s own and other people’s mental states. ToM is supposed to have two systems. The implicit ToM seems to be a fast, automatic, non-verbal processing. The explicit ToM is characterized by a slower, but more flexible processing, which is mostly verbal, interpretative. Several studies have described explicit ToM deficit in schizophrenic patients. Less research has investigated implicit ToM in patients, however recently, there has been a growing number of articles examining implicit ToM of patients with schizophrenia. Objectives The aim of our systematic review and meta-analysis is to summarize the results of the implicit ToM in schizophrenia. Methods A systematic search was performed in four major databases. We included 11 publications. 7 studies; and 5 studies were included the quantitative synthesis and the qualitative synthesis, respectively. Results We found significant differences in accuracy, reaction time and brain activation patterns during implicit ToM between schizophrenic patients and controls. The systematic review revealed further alterations in visual scanning, cue fixation, face looking time, and difficulties in perspective taking. Conclusions Based on our results implicit ToM is affected in schizophrenia in addition to explicit ToM deficit. However, based on these results we cannot exclude the possibility, that implicit ToM or at least some elements of it might be relatively unaffected (e.g. detection of intentionality), however its effectiveness is limited by non-mentalizing deficits (e.g. certain neurocognitive impairments). Our results may have important implications for the remediation of mentalizing skills. Disclosure The research is supported by the Hungarian National Excellence Centrum Grant (FIKP II) and Hungarian Brain Research Program (KTIA-13-NAP-A-II/12).
Collapse
|
3
|
Ramirez Hincapie S, Herold M, Sperber S, Birk B, Haake V, Giri V, Huener HA, Verlohner A, Kamp H, Landsiedel R, Richling E, Van Ravenzwaay B. Miniaturization of in vitro liver metabolomics - a screening approach to predict the mode of action of liver toxicants in HepG2 cells. Toxicol Lett 2021. [DOI: 10.1016/s0378-4274(21)00470-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
4
|
Herold M, Kalavsky E. Delivery of blistered Medicines as an Important Factor in Medication Safety and Maintaining Patient Health in Times of Lockdown due to COVID-19. cswhi 2021. [DOI: 10.22359/cswhi_12_2_08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The whole world is holding its breath and has fallen into a kind of paralysis of shock: the Corona pandemic is affecting the lives of every single person on Earth. Many have fallen ill, many have died, almost everyone is in lockdown. But everyday processes must continue, under special conditions, yet they must continue to function. Among them is the supply of medicines to the population. Here the question arises as to whether a higher level of medication safety, especially in a situation with an extremely stressed external environment, can be provided by blistering. In this context, it is relevant what exactly blistering means, which advantages and disadvantages are associated with it, for which reasons blistering is used and whether more safety for medication can be achieved through it. This is the subject of the following remarks.
Collapse
|
5
|
Loibner E, Ritschl V, Leeb B, Spellitz P, Eichbauer-Sturm G, Zwerina J, Herold M, Stetter M, Puchner R, Singer F, Fritsch-Stork R. POS0208 GENDER DIFFERENCES IN RESPONSE TO BIOLOGICALS. WOMEN FARE WORSE ACROSS INFLAMMATORY ARTHRITIS DISEASES - DATA FROM THE BIOREG. Ann Rheum Dis 2021. [DOI: 10.1136/annrheumdis-2021-eular.3596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Background:Gender differences in prevalence and disease course are known in various rheumatic diseases; however, investigations of gender difference concerning therapeutical response have yielded variable results.Objectives:The aim of this retrospective study was to investigate, whether a gender difference in response rate to biological disease-modifying antirheumatic drugs (bDMARDs) and apremilast in bDMARD-naïve patients could be observed across the three most prevalent inflammatory arthritis diseases: rheumatoid arthritis (RA), spondylarthritis (SpA) and psoriatic arthritis (PsA). Additionally, a response to individual TNF blockers was investigated in this respect.Methods:Data from bDMARD-naïve RA-, SpA- and PsA-patients from Bioreg, the Austrian registry for biological DMARDs in rheumatic diseases, were used. Patients with a baseline (Visit 1=V1) and follow-up visits at 6 months (Visit 2=V2) and 12 months (Visit 3=V3) were included and response to therapy with TNF-inhibitors (TNFi), furthermore to therapy with rituximab, tocilizumab and apremilast was analyzed according to gender. The remaining bDMARDs were not analyzed due to small numbers. Key response-parameter for RA was disease activity score (DAS28), whereas for PsoA the Stockerau Activity Score for Psoriatic Arthritis (SASPA) and for SpA the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were employed; in addition, the Health assessment Questionnaire (HAQ) was used. Data were analyzed in R Statistic stratified by gender using Kruskal-Wallis and Wilcoxon tests.Results:354 women and 123 men with RA (n=477), 81 women and 69 men with PsA (n=150), 121 women and 191 men with SpA (n=312) were included. No significant differences in biometrics was seen between female and male patients at baseline in all diseases.In RA patients overall DAS28 decreased from baseline (V1) to V2 and V3 (DAS28: V1: male: 4.38 [3.66, 5.11], female: 4.30 [3.68, 5.03], p(m/f) = 0.905; V2: male: 2.66 [1.73, 3.63], female: 3.10 [2.17, 3.98], p(m/f) = 0.015; V3: male: 2.25 [1.39, 3.36], female: 3.01 [1.87, 3.87], p(m/f) = 0.002). For TNF inhibitors (n=311), there was a significant difference between genders at V2 (Fig.1a). Patients receiving Rituximab (n=41) displayed a significantly higher DAS28 at baseline in females, which diminished in the follow up: V1: (p(m/f) p=0.002; V2: p=0.019; V3: p=0.13); response to tocilizumab (n=63) did not show any gender differences.In PsA patients overall SASPA decreased from baseline (V1) to V2 and V3 (SASPA: V1: male: 4.00 [2.80, 5.20], female: 4.40 [2.80, 5.80], p(m/f) = 0.399; V2: male: 2.20 [1.20, 3.50], female: 3.40 [2.00, 5.00], p(m/f) = 0.071; V3: male: 1.80 [0.80, 2.70], female: 3.01 [2.35, 4.80], p(m/f) = 0.001). For TNF inhibitors (n=79), there was a significant difference between genders at V3 (Fig 1a). For Apremilast (n=39), there was a significant difference between genders at V2 (Fig.1c).In SpA patients overall BASDAI decreased from baseline (V1) to V2 and V3 (BASDAI: V1: male: 4.70 [2.88, 6.18], female: 4.80 [3.30, 6.20], p(m/f) = 0.463; V2: male: 3.05 [2.00, 4.60], female: 3.64 [2.62, 5.41], p(m/f) = 0.039; V3: male: 3.02 [1.67, 4.20], female: 3.65 [2.18, 5.47], p(m/f) = 0.016). In V3 a differential BASDAI in response to TNFi (n=299) was observed (Fig.1a).Possible differences of response to individual TNFi (etanercept, infliximab, other TNFi) measured by HAQ were investigated in all diseases together. The difference between male and females was significant at baseline for all 3 TNFi; whereas with the use of ETA the significant difference was carried through to V2 and V3, it was lost with the use of IFX and was variable with the other TNFi (Fig.1b)Figure 1.Conclusion:Female patients showed a statistically lower response to TNFi in all three disease entities (RA, SpA and PsoA) to a variable degree in our homogenous central european population. Interestingly, the difference was not uniform across individual TNFi when measured by HAQ. Gender differences were also seen in response to Apremilast.Disclosure of Interests:Elisabeth Loibner: None declared, Valentin Ritschl: None declared, Burkhard Leeb Speakers bureau: AbbVie, Roche, MSD, Pfizer, Actiopharm, Boehringer-Ingelheim, Kwizda, Celgene, Sandoz, Grünenthal, Eli-Lilly, Grant/research support from: TRB, Roche, Consultancies: AbbVie, Amgen, Roche, MSD, Pfizer, Celgene, Grünenthal, Kwizda, Eli-Lilly, Novartis, Sandoz;, Peter Spellitz: None declared, Gabriela Eichbauer-Sturm: None declared, Jochen Zwerina: None declared, Manfred Herold: None declared, Miriam Stetter: None declared, Rudolf Puchner Speakers bureau: AbbVie, BMS, Janssen, Kwizda, MSD, Pfizer, Celgene, Grünenthal, Eli-Lilly, Consultant of: AbbVie, Amgen, Pfizer, Celgene, Grünenthal, Eli-Lilly, Franz Singer: None declared, Ruth Fritsch-Stork: None declared
Collapse
|
6
|
Herold M, Kalavsky E. Logistics, as Intervention to Secure the Supply of Medicines to Healthcare Facilities by Pharmacies and other Drug Manufacturers and Suppliers. cswhi 2020. [DOI: 10.22359/cswhi_11_2_09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
7
|
Jackson T, Shenkin A, Moore J, Bunce A, van Emmerik T, Kane B, Burcham D, James K, Selker J, Calders K, Origo N, Disney M, Burt A, Wilkes P, Raumonen P, Gonzalez de Tanago Menaca J, Lau A, Herold M, Goodman RC, Fourcaud T, Malhi Y. An architectural understanding of natural sway frequencies in trees. J R Soc Interface 2019; 16:20190116. [PMID: 31164076 DOI: 10.1098/rsif.2019.0116] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The relationship between form and function in trees is the subject of a longstanding debate in forest ecology and provides the basis for theories concerning forest ecosystem structure and metabolism. Trees interact with the wind in a dynamic manner and exhibit natural sway frequencies and damping processes that are important in understanding wind damage. Tree-wind dynamics are related to tree architecture, but this relationship is not well understood. We present a comprehensive view of natural sway frequencies in trees by compiling a dataset of field measurement spanning conifers and broadleaves, tropical and temperate forests. The field data show that a cantilever beam approximation adequately predicts the fundamental frequency of conifers, but not that of broadleaf trees. We also use structurally detailed tree dynamics simulations to test fundamental assumptions underpinning models of natural frequencies in trees. We model the dynamic properties of greater than 1000 trees using a finite-element approach based on accurate three-dimensional model trees derived from terrestrial laser scanning data. We show that (1) residual variation, the variation not explained by the cantilever beam approximation, in fundamental frequencies of broadleaf trees is driven by their architecture; (2) slender trees behave like a simple pendulum, with a single natural frequency dominating their motion, which makes them vulnerable to wind damage and (3) the presence of leaves decreases both the fundamental frequency and the damping ratio. These findings demonstrate the value of new three-dimensional measurements for understanding wind impacts on trees and suggest new directions for improving our understanding of tree dynamics from conifer plantations to natural forests.
Collapse
Affiliation(s)
- T Jackson
- 1 Environmental Change Institute, School of Geography and the Environment, University of Oxford , Oxford OX1 3QY , UK
| | - A Shenkin
- 1 Environmental Change Institute, School of Geography and the Environment, University of Oxford , Oxford OX1 3QY , UK
| | - J Moore
- 2 Scion , 49 Sala Street, Rotorua 3010 , New Zealand
| | - A Bunce
- 3 Department of Natural Resources, University of Connecticut , Mansfield, CT 06269 , USA
| | - T van Emmerik
- 4 Water Resources Section, Delft University of Technology , Stevinweg 1, 2628 CN, Delft , The Netherlands.,5 Hydrology and Quantitative Water Management Group, Wageningen University , Wageningen , The Netherlands
| | - B Kane
- 6 Department of Environmental Conservation, University of Massachusetts , Amherst, MA 01003 , USA
| | - D Burcham
- 7 Centre for Urban Greenery and Ecology , National Parks Board, 259569 Singapore
| | - K James
- 8 School of Ecosystem and Forest Sciences, Faculty of Science, University of Melbourne , Melbourne , Australia
| | - J Selker
- 9 Oregon State University , Corvallis, OR 97331 , USA
| | - K Calders
- 10 CAVElab - Computational and Applied Vegetation Ecology, Ghent University , Ghent , Belgium
| | - N Origo
- 11 Earth Observation, Climate and Optical Group, National Physical Laboratory , Hampton Road, Teddington, Middlesex TW11 0LW , UK.,12 Department of Geography, University College London , London WC1E 6BT , UK
| | - M Disney
- 12 Department of Geography, University College London , London WC1E 6BT , UK.,13 NERC National Centre for Earth Observation (NCEO) , Leicester , UK
| | - A Burt
- 12 Department of Geography, University College London , London WC1E 6BT , UK
| | - P Wilkes
- 12 Department of Geography, University College London , London WC1E 6BT , UK.,13 NERC National Centre for Earth Observation (NCEO) , Leicester , UK
| | - P Raumonen
- 14 Tampere University of Technology , Korkeakoulunkatu 10, 33720 Tampere , Finland
| | - J Gonzalez de Tanago Menaca
- 15 Laboratory of Geo-Information Science and Remote Sensing, Wageningen University , Droevendaalsesteeg 3, 6708 PB Wageningen , The Netherlands.,16 Center for International Forestry Research (CIFOR) , PO Box 0113 BOCBD, Bogor 16000 , Indonesia
| | - A Lau
- 15 Laboratory of Geo-Information Science and Remote Sensing, Wageningen University , Droevendaalsesteeg 3, 6708 PB Wageningen , The Netherlands.,16 Center for International Forestry Research (CIFOR) , PO Box 0113 BOCBD, Bogor 16000 , Indonesia
| | - M Herold
- 15 Laboratory of Geo-Information Science and Remote Sensing, Wageningen University , Droevendaalsesteeg 3, 6708 PB Wageningen , The Netherlands
| | - R C Goodman
- 17 Department of Forest Ecology and Management, Swedish University of Agricultural Sciences , Umeå , Sweden
| | - T Fourcaud
- 18 AMAP, University of Montpellier, CIRAD, CNRS, INRA, IRD , Montpellier , France
| | - Y Malhi
- 1 Environmental Change Institute, School of Geography and the Environment, University of Oxford , Oxford OX1 3QY , UK
| |
Collapse
|
8
|
Duncanson L, Armston J, Disney M, Avitabile V, Barbier N, Calders K, Carter S, Chave J, Herold M, Crowther TW, Falkowski M, Kellner JR, Labrière N, Lucas R, MacBean N, McRoberts RE, Meyer V, Næsset E, Nickeson JE, Paul KI, Phillips OL, Réjou-Méchain M, Román M, Roxburgh S, Saatchi S, Schepaschenko D, Scipal K, Siqueira PR, Whitehurst A, Williams M. The Importance of Consistent Global Forest Aboveground Biomass Product Validation. Surv Geophys 2019; 40:979-999. [PMID: 31395994 PMCID: PMC6647371 DOI: 10.1007/s10712-019-09538-8] [Citation(s) in RCA: 30] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Accepted: 04/27/2019] [Indexed: 05/17/2023]
Abstract
Several upcoming satellite missions have core science requirements to produce data for accurate forest aboveground biomass mapping. Largely because of these mission datasets, the number of available biomass products is expected to greatly increase over the coming decade. Despite the recognized importance of biomass mapping for a wide range of science, policy and management applications, there remains no community accepted standard for satellite-based biomass map validation. The Committee on Earth Observing Satellites (CEOS) is developing a protocol to fill this need in advance of the next generation of biomass-relevant satellites, and this paper presents a review of biomass validation practices from a CEOS perspective. We outline the wide range of anticipated user requirements for product accuracy assessment and provide recommendations for the validation of biomass products. These recommendations include the collection of new, high-quality in situ data and the use of airborne lidar biomass maps as tools toward transparent multi-resolution validation. Adoption of community-vetted validation standards and practices will facilitate the uptake of the next generation of biomass products.
Collapse
Affiliation(s)
- L. Duncanson
- Department of Geographical Sciences, University of Maryland, College Park, 2181 Lefrak Hall, College Park, MD 20742 USA
| | - J. Armston
- Department of Geographical Sciences, University of Maryland, College Park, 2181 Lefrak Hall, College Park, MD 20742 USA
| | - M. Disney
- Department of Geography, University College London, Gower Street, London, WC1E 6BT UK
| | - V. Avitabile
- European Commission, Joint Research Centre (JRC), Via E. Fermi 2749, 21027 Ispra, Italy
| | - N. Barbier
- AMAP, IRD, CIRAD,
CNRS, INRA, Montpellier University, TA A51/PS2, 34398 Montpellier cedex 5, France
| | - K. Calders
- CAVElab – Computational and Applied Vegetation Ecology, Ghent University, Room A2.089, Coupure Links 653, 9000 Ghent, Belgium
| | - S. Carter
- Laboratory of Geo-Information Science and Remote Sensing, Wageningen University and Research, Droevendaalsesteeg 3, 6708 PB Wageningen, The Netherlands
| | - J. Chave
- Laboratoire Evolution et Diversit. Biologique, UMR 5174, CNRS, Universit. Toulouse Paul Sabatier, 118 route de Narbonne, 31062 Toulouse cedex 9, France
| | - M. Herold
- Laboratory of Geo-Information Science and Remote Sensing, Wageningen University and Research, Droevendaalsesteeg 3, 6708 PB Wageningen, The Netherlands
| | - T. W. Crowther
- Institute of Integrative Biology, ETH Zürich, Univeritätstrasse 16, 8006 Zurich, Switzerland
| | - M. Falkowski
- Department of Ecosystem Science and Sustainability, Colorado State University, Fort Collins, CO 80523 USA
| | - J. R. Kellner
- Institute at Brown for Environment and Society, Brown University, Providence, RI 02912 USA
- Department of Ecology and Evolutionary Biology, Brown University, Providence, RI 02912 USA
| | - N. Labrière
- Laboratoire Evolution et Diversit. Biologique, UMR 5174, CNRS, Universit. Toulouse Paul Sabatier, 118 route de Narbonne, 31062 Toulouse cedex 9, France
| | - R. Lucas
- Earth Observation and Ecosystem Dynamics Research Group, Department of Geography and Earth Sciences (DGES), Aberystwyth University, Aberystwyth, Wales SY23 3DB UK
| | - N. MacBean
- Department of Geography, Indiana University, 701 E. Kirkwood Ave., Bloomington, IN 47405 USA
| | - R. E. McRoberts
- USDA Forest Service, Northern Research Station, Saint Paul, 1992 Folwell Ave, St Paul, MN 55108 USA
| | - V. Meyer
- Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA 91109 USA
| | - E. Næsset
- Faculty of Environmental Sciences and Natural Resource Management, Norwegian University of Life Sciences, NMBU, P.O. Box 5003, 1432 Ås, Norway
| | - J. E. Nickeson
- NASA Goddard Space Flight Center/Science Systems and Applications Inc., 10210 Greenbelt Rd #600, Lanham, MD 20706 USA
| | - K. I. Paul
- CSIRO Land and Water, GPO Box 1700, Canberra, ACT 2601 Australia
| | - O. L. Phillips
- School of Geography, University of Leeds, Leeds, LS2 9JT UK
| | - M. Réjou-Méchain
- AMAP, IRD, CIRAD,
CNRS, INRA, Montpellier University, TA A51/PS2, 34398 Montpellier cedex 5, France
| | - M. Román
- Earth from Space Institute, Universities Space Research Association, Columbia, MD USA
| | - S. Roxburgh
- CSIRO Land and Water, GPO Box 1700, Canberra, ACT 2601 Australia
| | - S. Saatchi
- Jet Propulsion Laboratory, California Institute of Technology, Pasadena, CA 91109 USA
| | - D. Schepaschenko
- International Institute for Applied Systems Analysis, Schlossplatz 1, 2361 Laxenburg, Austria
| | - K. Scipal
- European Space Agency, ESTEC, Keplerlaan 1, 2201 AZ Noordwijk, The Netherlands
| | - P. R. Siqueira
- Department of Electrical and Computer Engineering, 201 Marcus Hall, University of Massachusetts, 100 Natural Resources Road, Amherst, MA 01003 USA
| | - A. Whitehurst
- Arctic Slope Federal Technical Services, 7000 Muirkirk Meadows Dr #100, Laurel, MD 20707 USA
| | - M. Williams
- School of GeoScience, University of Edinburgh, Drummond St, Edinburgh, EH8 9XP UK
| |
Collapse
|
9
|
Behr C, Sperber S, Jiang X, Strauss V, Kamp H, Walk T, Herold M, Beekmann K, Rietjens I, van Ravenzwaay B. Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics. Toxicol Appl Pharmacol 2018; 355:198-210. [DOI: 10.1016/j.taap.2018.06.028] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2018] [Revised: 04/09/2018] [Accepted: 06/26/2018] [Indexed: 12/30/2022]
|
10
|
Behr C, Ramírez-Hincapié S, Cameron HJ, Strauss V, Walk T, Herold M, Beekmann K, Rietjens IMCM, van Ravenzwaay B. Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces. Toxicol Lett 2018; 296:139-151. [PMID: 30102961 DOI: 10.1016/j.toxlet.2018.08.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 07/31/2018] [Accepted: 08/02/2018] [Indexed: 11/16/2022]
Abstract
The importance of the gut microorganisms and their wide range of interactions with the host are well-acknowledged. In this study, lincomycin and clindamycin were used to modulate microbial communities of Wistar rats to gain a comprehensive understanding of the implications of microbiome alterations. A metabolomics approach and taxonomic profiling were applied to characterize the effects of these antibiotics on the functionality of the microbiome and to identify microbiome-related metabolites. After treatment, the diversity of the microbial community was drastically reduced. Bacteroidetes and Verrucomicrobia were drastically reduced, Tenericutes and Deferribacteres completely disappeared, while abundance of Firmicutes and Proteobacteria were highly increased. Changes in plasma and feces metabolites were observed for metabolites belonging mainly to the class of complex lipids, fatty acids and related metabolites as well as amino acids and related compounds. Bile acid metabolism was markedly affected: taurocholic acid, glycochenodeoxycholic acid and cholic acid presented abrupt changes showing a specific metabolite pattern indicating disruption of the microbial community. In both plasma and feces taurocholic acid was highly upregulated upon treatment whereas glycochenodeoxycholic acid was downregulated. Cholic acid was upregulated in feces but downregulated in plasma. These results show that changes in the gut microbial community lead to alterations of the metabolic profile in blood and feces of the host and can be used to identify potentially microbiome-related metabolites. This implies that metabolomics could be a suitable tool to estimate the extent of changes induced in the intestinal microbiome with respect to consequences for the host.
Collapse
Affiliation(s)
- C Behr
- BASF SE, 67056, Ludwigshafen, Germany
| | | | - H J Cameron
- BASF Plant Science LP, Research Triangle Park, USA
| | - V Strauss
- BASF SE, 67056, Ludwigshafen, Germany
| | - T Walk
- metanomics GmbH, 10589, Berlin, Germany
| | - M Herold
- metanomics GmbH, 10589, Berlin, Germany
| | - K Beekmann
- Division of Toxicology, Wageningen University, 6700 EA, Wageningen, The Netherlands
| | - I M C M Rietjens
- Division of Toxicology, Wageningen University, 6700 EA, Wageningen, The Netherlands
| | | |
Collapse
|
11
|
Reul H, Taguchi K, Herold M, Lo H, Reck B, MÜckter H, Messmer B, Rau G. Comparative Evaluation of Disk- and Tri Leaflet Valves in Left-Ventricular Assist Devices (LVAD). Int J Artif Organs 2018. [DOI: 10.1177/039139888801100213] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Two identical LVADs were equipped with different types of heart valve prostheses (Björk-Shiley disk and PU-valves) and tested in two simultaneous calf experiments for 28 days each. Noise levels, accelerations of the pump housing and thrombus formation were higher for the mechanical valve pump.
Collapse
Affiliation(s)
- H. Reul
- Helmholtz-lnstitut für Biomedizinische Technik, Aachen, FRG
| | - K. Taguchi
- 4-10-3 Ushita-Higashi-Ku, Hiroshima, Japan
| | - M. Herold
- Helmholtz-lnstitut für Biomedizinische Technik, Aachen, FRG
| | - H.B. Lo
- Abteilung Thorax-, Herz- und Gefässchirurgie, Klinikum Aachen, FRG
| | - B. Reck
- Helmholtz-lnstitut für Biomedizinische Technik, Aachen, FRG
| | - H. MÜckter
- Abteilung Thorax-, Herz- und Gefässchirurgie, Klinikum Aachen, FRG
| | - B.J. Messmer
- Abteilung Thorax-, Herz- und Gefässchirurgie, Klinikum Aachen, FRG
| | - G. Rau
- Helmholtz-lnstitut für Biomedizinische Technik, Aachen, FRG
| |
Collapse
|
12
|
Hoster E, Unterhalt M, Hänel M, Prange-Krex G, Forstpointner R, Florschütz A, Graeven U, Frickhofen N, Wulf G, Lengfelder E, Lerchenmüller C, Schlag R, Dierlamm J, Fischer Von Weikersthal L, Ahmed A, Harich H, Rosenwald A, Klapper W, Dreyling M, Hiddemann W, Herold M. RITUXIMAB MAINTENANCE VERSUS OBSERVATION AFTER IMMUNOCHEMOTHERAPY (R-CHOP, R-MCP, R-FCM) IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RANDOMISED TRIAL OF GLSG AND OSHO. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_12] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- E. Hoster
- Medizinische Klinik III; Klinikum der Ludwig-Maximilians-Universität München; Munich Germany
| | - M. Unterhalt
- Medizinische Klinik III; Klinikum der Ludwig-Maximilians-Universität München; Munich Germany
| | - M. Hänel
- Klinik für Innere Medizin III; Klinikum Chemnitz; Chemnitz Germany
| | - G. Prange-Krex
- Innere Medizin, Hämatologie, Onkologie, Gemeinschaftspraxis; Dresden Germany
| | - R. Forstpointner
- Medizinische Klinik III; Klinikum der Ludwig-Maximilians-Universität München; Munich Germany
| | - A. Florschütz
- Klinik für Innere Medizin; Städtisches Klinikum Dessau; Dessau Germany
| | - U. Graeven
- Klinik für Hämatologie, Onkologie und Gastroenterologie; Kliniken Maria Hilf; Mönchengladbach Germany
| | - N. Frickhofen
- Klinik Innere Medizin III; HELIOS Dr. Horst Schmidt Kliniken Wiesbaden; Wiesbaden Germany
| | - G. Wulf
- Hämatologie und Medizinische Onkologie; Universitätsmedizin Göttingen; Göttingen Germany
| | - E. Lengfelder
- III. Medizinische Klinik; Klinikum Mannheim; Mannheim Germany
| | | | - R. Schlag
- Innere Medizin, Hämatologie u. Internistische Onkologie; Gemeinschaftspraxis; Würzburg Germany
| | - J. Dierlamm
- II. Medizinischen Klinik und Poliklinik; Universitätsklinikum Eppendorf; Hamburg Germany
| | | | - A. Ahmed
- Medizinische Klinik III; Städtisches Klinikum Braunschweig; Braunschweig Germany
| | - H. Harich
- Onkologie Hof, Medizinisches Versorgungszentrum; Hof Germany
| | - A. Rosenwald
- Institut für Pathologie; Universität Würzburg; Würzburg Germany
| | - W. Klapper
- Sektion Hämatopathologie und Lymphknotenregister; Universitätsklinikum Schleswig-Holstein; Kiel Germany
| | - M. Dreyling
- Medizinische Klinik III; Klinikum der Ludwig-Maximilians-Universität München; Munich Germany
| | - W. Hiddemann
- Medizinische Klinik III; Klinikum der Ludwig-Maximilians-Universität München; Munich Germany
| | - M. Herold
- Onkologisches Zentrum; HELIOS Klinikum Erfurt; Erfurt Germany
| |
Collapse
|
13
|
Herold M, Hoster E, Janssens A, McCarthy H, Tedeschi A, Pocock C, Rosta A, Schmidt P, Trněný M, Burciu A, Fingerle-Rowson G, Rufibach K, Zeuner H, Hiddemann W, Marcus R. IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN a SUBSET OF PATIENTS IN THE RANDOMISED GALLIUM TRIAL WITH PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA (MZL). Hematol Oncol 2017. [DOI: 10.1002/hon.2437_136] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- M. Herold
- Oncology Center, HELIOS-Klinikum Erfurt; Erfurt Germany
| | - E. Hoster
- Department of Medicine III; Ludwig-Maximilians-University Hospital Munich; Munich Germany
| | - A. Janssens
- Department of Haematology; UZ Leuven; Leuven Belgium
| | - H. McCarthy
- Department of Haematology; Royal Bournemouth General Hospital; Bournemouth UK
| | - A. Tedeschi
- Division of Hematology; A. O. Ospedale Niguarda Ca’ Granda; Milan Italy
| | - C. Pocock
- Department of Haematology; Kent & Canterbury Hospital; Canterbury UK
| | - A. Rosta
- Department of Haematology, Országos Onkológiai Intézet; Budapest Hungary
| | - P. Schmidt
- Dr. med. Peter Schmidt; Praxis Neunkirchen/Saar Germany
| | - M. Trněný
- 1st Department of Medicine; Charles University General Hospital; Prague Czech Republic
| | - A. Burciu
- Pharma Development Safety and Risk Management; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - G. Fingerle-Rowson
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - K. Rufibach
- Pharma Development Biometrics Biostatistics; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - H. Zeuner
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - W. Hiddemann
- Department of Medicine III; Ludwig-Maximilians-University Hospital Munich; Munich Germany
| | - R. Marcus
- Department of Haematology; Kings College Hospital; London UK
| |
Collapse
|
14
|
Fornecker L, Ou F, Dixon J, Casulo C, Hoster E, Hiddemann W, Sebban C, Morschhauser F, Marcus R, Hochster H, Rummel M, Hagenbeeck A, Kimby E, Herold M, Peterson B, Gyan E, Ladetto M, Zucca E, Nielsen T, Foon K, Vitolo U, Flowers C, Shi Q, Salles G. CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST-LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_89] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- L. Fornecker
- Department of Hematology; University Hospital of Strasbourg; Strasbourg France
| | - F. Ou
- Division of Biomedical Statistics and Informatics, Mayo Clinic; Rochester USA
| | - J.G. Dixon
- Division of Biomedical Statistics and Informatics, Mayo Clinic; Rochester USA
| | - C. Casulo
- School of Medicine and Dentistry; University of Rochester Medical Center; Rochester USA
| | - E. Hoster
- Department of Internal Medicine III; Ludwig-Maximilians University Hospital, Campus Großhadern; Munich Germany
| | - W. Hiddemann
- Department of Internal Medicine III; Ludwig-Maximilians University Hospital, Campus Großhadern; Munich Germany
| | - C. Sebban
- Onco-Hematology, Centre Leon Berard; University Claude Bernard Lyon 1; Lyon France
| | - F. Morschhauser
- Department of Clinical Hematology; Centre Hospitalier Universitaire, Université de Lille; Lille France
| | - R. Marcus
- Department of Haematology; Addenbrookes Hospital; Cambridge UK
| | - H. Hochster
- Yale Cancer Center; Department of Medicine; New Haven USA
| | - M. Rummel
- Medizinische Klinik IV; University Hospital; Gießen Germany
| | - A. Hagenbeeck
- Department of Hematology; Academic Medical Center; Amsterdam The Netherlands
| | - E. Kimby
- Hematology Centre at Karolinska University Hospital; Karolinska Institutet; Stockholm Sweden
| | - M. Herold
- Department of Hematology and Oncology, HELIOS Klinikum; Erfurt Germany
| | - B.A. Peterson
- Division of Hematology, Oncology and Transplantation; University of Minnesota; Minneapolis USA
| | - E. Gyan
- Department of Hematology and Cell Therapy; University Hospital; Tours France
| | - M. Ladetto
- Department of Hematology, Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo; Alessandria Italy
| | - E. Zucca
- Department of Hematology, Oncology Institute of Southern Switzerland (IOSI); Bellinzona Switzerland
| | - T. Nielsen
- Department of Medical Affairs; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - K. Foon
- Department of Medical Affairs, Celgene Corporation; Summit USA
| | - U. Vitolo
- Department of Hematology; Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino; Torino Italy
| | - C.R. Flowers
- Department of Bone Marrow and Stem Cell Transplantation; Winship Cancer Institute of Emory University; Atlanta USA
| | - Q. Shi
- Division of Biomedical Statistics and Informatics, Mayo Clinic; Rochester USA
| | - G. Salles
- Department of Hematology; Centre Hospitalier Lyon-Sud; Pierre-Benite France
| |
Collapse
|
15
|
Hiddemann W, Barbui A, Canales Albendea M, Cannell P, Collins G, Dürig J, Forstpointner R, Herold M, Hertzberg M, Klanova M, Radford J, Tobinai K, Burciu A, Fingerle-Rowson G, Nielsen T, Wolbers M, Marcus R. IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_106] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- W. Hiddemann
- Department of Medicine III; Ludwig-Maximilians-University Hospital Munich; Munich Germany
| | - A.M. Barbui
- Department of Hematology; Azienda Ospedaliera Papa Giovanni XXIII; Bergamo Italy
| | | | - P.K. Cannell
- Haematology Department; Fiona Stanley Hospital; Murdoch Australia
| | - G.P. Collins
- Department of Clinical Haematology; Oxford Cancer and Haematology Centre, Churchill Hospital; Oxford UK
| | - J. Dürig
- Medical Faculty (Haematology), Universitaetsklinikum Essen; Essen Germany
| | - R. Forstpointner
- Department of Medicine III; Ludwig-Maximilians-University Hospital Munich; Munich Germany
| | - M. Herold
- Oncology Center; HELIOS-Klinikum Erfurt; Erfurt Germany
| | - M. Hertzberg
- Department of Haematology; Prince of Wales Hospital; Sydney Australia
| | - M. Klanova
- 1st Department of Medicine; Charles University General Hospital, Prague, Czech Republic and Pharma Development Clinical Oncology, F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - J.A. Radford
- Manchester Academic Health Science Centre; The University of Manchester and The Christie NHS Foundation Trust; Manchester UK
| | - K. Tobinai
- Department of Hematology; National Cancer Center Hospital; Tokyo Japan
| | - A. Burciu
- Pharma Development Safety and Risk Management; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - G.R. Fingerle-Rowson
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - T. Nielsen
- Pharma Development Clinical Oncology; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - M. Wolbers
- Pharma Development Biometrics Biostatistics; F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - R. Marcus
- Department of Haematology; Kings College Hospital; London UK
| |
Collapse
|
16
|
|
17
|
Herold M, Eichbauer-Sturm G, Puchner R, Rintelen B, Singer F, Leeb B. SAT0073 Good Therapeutic Response with Biologics but Patients' and Physicians' Opinion Are Different. Data from The Austrian Bioreg Registry. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
18
|
Chan EKL, Damoiseaux J, de Melo Cruvinel W, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, Garcia-De La Torre I, Herold M, Mimori T, Satoh M, von Mühlen CA, Andrade LEC. Report on the second International Consensus on ANA Pattern (ICAP) workshop in Dresden 2015. Lupus 2016; 25:797-804. [DOI: 10.1177/0961203316640920] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The second meeting for the International Consensus on Antinuclear antibody (ANA) Pattern (ICAP) was held on 22 September 2015, one day prior to the opening of the 12th Dresden Symposium on Autoantibodies in Dresden, Germany. The ultimate goal of ICAP is to promote harmonization and understanding of autoantibody nomenclature, and thereby optimizing ANA usage in patient care. The newly developed ICAP website www.ANApatterns.org was introduced to the more than 50 participants. This was followed by several presentations and discussions focusing on key issues including the two-tier classification of ANA patterns into competent-level versus expert-level, the consideration of how to report composite versus mixed ANA patterns, and the necessity for developing a consensus on how ANA results should be reported. The need to establish on-line training modules to help users gain competency in identifying ANA patterns was discussed as a future addition to the website. To advance the ICAP goal of promoting wider international participation, it was agreed that there should be a consolidated plan to translate consensus documents into other languages by recruiting help from members of the respective communities.
Collapse
Affiliation(s)
- E K L Chan
- Department of Oral Biology, University of Florida, Gainesville, Florida, USA
| | - J Damoiseaux
- Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands
| | | | - O G Carballo
- Laboratory of Immunology, Hospital Carlos G. Durand, and Department of Immunology, Instituto Universitario del Hospital Italiano, Buenos Aires, Argentina
| | - K Conrad
- Institute of Immunology, Technical University of Dresden, Dresden, Germany
| | | | - M J Fritzler
- Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
| | - I Garcia-De La Torre
- Department of Immunology and Rheumatology, Hospital General de Occidente and University of Guadalajara, Guadalajara, Mexico
| | - M Herold
- Department of Internal Medicine VI, Medical University of Innsbruck, Innsbruck, Austria
| | - T Mimori
- Department of the Control for Rheumatic Diseases and Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - M Satoh
- Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan
| | | | - L E C Andrade
- Rheumatology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo; Immunology Division, Fleury Medicine and Health Laboratories, São Paulo, Brazil
| |
Collapse
|
19
|
Salvini G, Ligtenberg A, van Paassen A, Bregt AK, Avitabile V, Herold M. REDD+ and climate smart agriculture in landscapes: A case study in Vietnam using companion modelling. J Environ Manage 2016; 172:58-70. [PMID: 26921566 DOI: 10.1016/j.jenvman.2015.11.060] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/03/2015] [Revised: 10/09/2015] [Accepted: 11/30/2015] [Indexed: 06/05/2023]
Abstract
Finding land use strategies that merge land-based climate change mitigation measures and adaptation strategies is still an open issue in climate discourse. This article explores synergies and trade-offs between REDD+, a scheme that focuses mainly on mitigation through forest conservation, with "Climate Smart Agriculture", an approach that emphasizes adaptive agriculture. We introduce a framework for ex-ante assessment of the impact of land management policies and interventions and for quantifying their impacts on land-based mitigation and adaptation goals. The framework includes a companion modelling (ComMod) process informed by interviews with policymakers, local experts and local farmers. The ComMod process consists of a Role-Playing Game with local farmers and an Agent Based Model. The game provided a participatory means to develop policy and climate change scenarios. These scenarios were then used as inputs to the Agent Based Model, a spatially explicit model to simulate landscape dynamics and the associated carbon emissions over decades. We applied the framework using as case study a community in central Vietnam, characterized by deforestation for subsistence agriculture and cultivation of acacias as a cash crop. The main findings show that the framework is useful in guiding consideration of local stakeholders' goals, needs and constraints. Additionally the framework provided beneficial information to policymakers, pointing to ways that policies might be re-designed to make them better tailored to local circumstances and therefore more effective in addressing synergistically climate change mitigation and adaptation objectives.
Collapse
Affiliation(s)
- G Salvini
- Laboratory of Geo-Information Science & Remote Sensing, Wageningen University, PO Box 47, 6700 AA Wageningen, The Netherlands.
| | - A Ligtenberg
- Laboratory of Geo-Information Science & Remote Sensing, Wageningen University, PO Box 47, 6700 AA Wageningen, The Netherlands
| | - A van Paassen
- Knowledge Technology and Innovation Group, Wageningen University, PO Box 47, 6700 AA Wageningen, The Netherlands
| | - A K Bregt
- Laboratory of Geo-Information Science & Remote Sensing, Wageningen University, PO Box 47, 6700 AA Wageningen, The Netherlands
| | - V Avitabile
- Laboratory of Geo-Information Science & Remote Sensing, Wageningen University, PO Box 47, 6700 AA Wageningen, The Netherlands
| | - M Herold
- Laboratory of Geo-Information Science & Remote Sensing, Wageningen University, PO Box 47, 6700 AA Wageningen, The Netherlands
| |
Collapse
|
20
|
Fleury I, Chevret S, Pfreundschuh M, Salles G, Coiffier B, van Oers M, Gisselbrecht C, Zucca E, Herold M, Ghielmini M, Thieblemont C. Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis. Ann Oncol 2016; 27:390-7. [DOI: 10.1093/annonc/mdv616] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2015] [Accepted: 11/30/2015] [Indexed: 12/17/2022] Open
|
21
|
Sochalska M, Ottina E, Tuzlak S, Herzog S, Herold M, Villunger A. Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival. Cell Death Differ 2015; 23:628-39. [PMID: 26450454 PMCID: PMC4986635 DOI: 10.1038/cdd.2015.130] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2015] [Revised: 08/19/2015] [Accepted: 08/27/2015] [Indexed: 11/09/2022] Open
Abstract
Bcl2 family proteins control mitochondrial apoptosis and its members exert critical cell type and differentiation stage-specific functions, acting as barriers against autoimmunity or transformation. Anti-apoptotic Bcl2a1/Bfl1/A1 is frequently deregulated in different types of blood cancers in humans but its physiological role is poorly understood as quadruplication of the Bcl2a1 gene locus in mice hampers conventional gene targeting strategies. Transgenic overexpression of A1, deletion of the A1-a paralogue or constitutive knockdown in the hematopoietic compartment of mice by RNAi suggested rate-limiting roles in lymphocyte development, granulopoiesis and mast cell activation. Here we report on the consequences of conditional knockdown of A1 protein expression using a reverse transactivator (rtTA)-driven approach that highlights a critical role for this Bcl2 family member in the maintenance of mature B-cell homeostasis. Furthermore, we define the A1/Bim (Bcl-2 interacting mediator of cell death) axis as a target of key kinases mediating B-cell receptor (BCR)-dependent survival signals, such as, spleen tyrosine kinase (Syk) and Brutons tyrosine kinase (Btk). As such, A1 represents a putative target for the treatment of B-cell-related pathologies depending on hyperactivation of BCR-emanating survival signals and loss of A1 expression accounts, in part, for the pro-apoptotic effects of Syk- or Btk inhibitors that rely on the ‘BH3-only' protein Bim for cell killing.
Collapse
Affiliation(s)
- M Sochalska
- Division of Developmental Immunology, Biocenter, Medical University Innsbruck, Innsbruck, Austria
| | - E Ottina
- Division of Developmental Immunology, Biocenter, Medical University Innsbruck, Innsbruck, Austria
| | - S Tuzlak
- Division of Developmental Immunology, Biocenter, Medical University Innsbruck, Innsbruck, Austria
| | - S Herzog
- Division of Developmental Immunology, Biocenter, Medical University Innsbruck, Innsbruck, Austria
| | - M Herold
- The Walter and Eliza Hall Institute for Medical Research, University of Melbourne, Parkville, Victoria, Australia.,Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia
| | - A Villunger
- Division of Developmental Immunology, Biocenter, Medical University Innsbruck, Innsbruck, Austria
| |
Collapse
|
22
|
Montoya G, Strauss V, Kamp H, Fabian E, Herold M, Krennrich G, Looser R, Mellert W, Peter E, Spitzer M, Walk T, van Ravenzwaay B. Metabolome differences in pregnancy and lactation compared to non-pregnant Wistar rats. Toxicol Lett 2015. [DOI: 10.1016/j.toxlet.2015.08.679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
23
|
Rosner J, Mosheimer-Feistritzer B, Gruber J, Herold M, Mur E, Weiss G. FRI0083 Prevalence of Anemia in a Cohort of Rheumatoid Arthritis Patients- An Interim Analysis. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2745] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Rintelen B, Herold M, Singer F, Hitzelhammer J, Zwerina J, Halder W, Eichbauer-Sturm G, Puchner R, Stetter M, Leeb B. AB0241 After one Year of Treatment with Biologicals, “Newcomers” Achieve a Comparable Outcome as Patients on Long Lasting Treatment. Characteristics of Austrian Rheumatoid Arthritis Patients; one Year Follow up Data from Bioreg, the Austrian Registry for Biologicals. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
25
|
Rintelen B, Herold M, Singer F, Hitzelhammer J, Zwerina J, Halder W, Eichbauer-Sturm G, Puchner R, Stetter M, Leeb B. THU0195 After One Year of Treatment with Biologicals, “Newcomers” Achieve a Comparable Outcome as Patients on Long Lasting Treatment. Characteristics of Austrian Patients with Psoriatic Arthritis and Spondylarthritis; One-year Follow up Data From Bioreg, the Austrian Registry for Biologicals. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.3044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
26
|
Herold M, Eichbauer-Sturm G, Puchner R, Rintelen B, Singer F, Leeb B. FRI0172 Commonplace Though not Approved – Monotherapy with Biologics. Data from the Austrian Bioreg Registry. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
27
|
Formosa C, Herold M, Vidaillac C, Duval RE, Dague E. Unravelling of a mechanism of resistance to colistin inKlebsiella pneumoniaeusing atomic force microscopy. J Antimicrob Chemother 2015; 70:2261-70. [DOI: 10.1093/jac/dkv118] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2014] [Accepted: 04/08/2015] [Indexed: 11/13/2022] Open
|
28
|
Herold M, May I, Nicolas A. Development and validation of three methods: liquid chromatography, flow injection analysis and UV spectrophotometry for the routine control of nystatin capsules. Eur J Hosp Pharm 2015. [DOI: 10.1136/ejhpharm-2014-000494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
29
|
Krämer M, Brauner S, Herold M, Diehl R, Dziobek I, Berlit P. Theory of Mind, Prosodieerkennung und Empathie bei sekundär progredienter Multipler Sklerose. Akt Neurol 2014. [DOI: 10.1055/s-0034-1370029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- M. Krämer
- Klinik für Neurologie, Alfried Krupp-Krankenhaus Essen
| | - S. Brauner
- Klinik für Neurologie, Alfried Krupp-Krankenhaus Essen
| | - M. Herold
- Klinik und Poliklinik für Psychiatrie und Psychotherapie des Klinikums rechts der Isar, München
| | - R. Diehl
- Klinik für Neurologie, Alfried Krupp-Krankenhaus Essen
| | - I. Dziobek
- Freie Universität Berlin, Arbeitsbereich Emotionspsychologie und affektive Neurowissenschaft, Cluster Languages of Emotion, Berlin
| | - P. Berlit
- Klinik für Neurologie, Alfried Krupp-Krankenhaus Essen
| |
Collapse
|
30
|
van Ravenzwaay B, Montoya G, Fabian E, Herold M, Krennrich G, Looser R, Mellert W, Peter E, Strauss V, Walk T, Kamp H. The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective. Toxicol Lett 2014; 227:20-8. [DOI: 10.1016/j.toxlet.2014.03.004] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2014] [Revised: 03/06/2014] [Accepted: 03/10/2014] [Indexed: 10/25/2022]
|
31
|
Schulze-Koops H, Giacomelli R, Samborski W, Rednic S, Herold M, Yao R, Govoni M, Vastesaeger N, Weng HH. THU0198 Patient Evaluations of Autoinjectors for Delivery of Subcutaneous Golimumab for Treatment of Rheumatoid Arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.726] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
32
|
van Ravenzwaay B, Herold M, Kamp H, Montoya G, Fabian E, Looser R, Krennrich G, Mellert W, Prokoudine A, Strauss V, Walk T, Wiemer J. Metabolomics and REACH: quantitative biological activity relationships. Toxicol Lett 2013. [DOI: 10.1016/j.toxlet.2013.06.096] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
33
|
Montoya G, Strauss V, Fabian E, Kamp H, Mellert W, Walk T, Looser R, Herold M, Krennrich G, Peter E, van Ravenzwaay B. Mechanistic explanation of different metabolomics patterns in rat plasma for the differentiation of direct thyroid hormone synthesis inhibitors and compounds increasing thyroid hormone clearance. Toxicol Lett 2013. [DOI: 10.1016/j.toxlet.2013.05.446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
34
|
Halder W, Klotz W, Herold M. AB0735 Antinuclear antibodies in aged people without signs of autoimmune disease. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.3057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
35
|
Eibl J, Klotz W, Herold M. AB0277 Antinuclear antibodies in patients with tnf- inhibitors. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
36
|
Vavrovsky M, Klotz W, Herold M. AB0734 Anti-sa antibody concentration does not change with disease activity in patients with rheumatoid arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.3056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
37
|
Herold M, Nicolas A, May I. TCH-006 Development and Validation of 3 Methods – UV Spectrophotometry, Flow Injection Analysis and Liquid Chromatography – For the Control of Nystatin Capsules. Eur J Hosp Pharm 2013. [DOI: 10.1136/ejhpharm-2013-000276.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
38
|
Paduch JH, Herold M, Krömker V. Diagnostische Eigenschaften eines neuen California-Mastitis-Tests. Tierarztl Prax Ausg G Grosstiere Nutztiere 2013. [DOI: 10.1055/s-0038-1623157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
Zusammenfassung
Gegenstand und Ziel: Um Sekretionsstörungen der bovinen Milchdrüse bereits frühzeitig in praxi identifizieren zu können, ist es notwendig, ein Testsystem mit einer hohen Sensitivität einzusetzen. Im Rahmen der vorliegenden Studie sollte daher untersucht werden, inwieweit durch die Verwendung eines Reagenz mit einer optimierten Rezeptur die Sensitivität des California-Mastitis-Tests im Vergleich zu einem kommerziell verfügbaren Produkt verbessert werden kann, sodass sich bereits Überschreitungen der Zellzahl von 100.000 Zellen/ml sicher erkennen lassen. Material und Methoden: In vitro wurden die Viskositäten von Gemischen aus Testmilchen mit standardisierten somatischen Zellgehalten (50.000-800.000 Zellen/ml) und Testreagenzien bestimmt. Insgesamt 50 Viertelanfangsgemelksproben von Tieren, die keine Anzeichen einer klinischen Mastitis aufwiesen, wurden geblindet mit dem California-Mastitis-Test unter Verwendung beider Testreagenzien untersucht. Sensitivität und Spezifität der Testsysteme wurden ermittelt. Ergebnisse: Mit zunehmendem somatischem Zellgehalt stieg die Viskosität der Gemische zu Beginn der rheologischen Messung. Bei einem Zellgehalt der Milch von 50.000 Zellen/ml ergab sich eine mittlere Viskosität von 3,20 mPa*s (kommerziell verfügbarer Test) bzw. 2,69 mPa*s (optimiertes Testreagens). Bei einem Milchzellgehalt von 100.000 Zellen/ml stieg die Viskosität auf 3,43 mPa*s (kommerziell verfügbarer Test) bzw. 4,58 mPa*s (optimiertes Testreagens) an. Die Sensitivität betrug bei Verwendung des kommerziell verfügbaren Testreagens 76,7% und unter Einsatz des optimierten Testreagens 97,7% bei einer Zellzahlgrenze von 100.000 Zellen/ml als Übergang vom physiologischen Zustand zu einer Sekretionsstörung. Schlussfolgerung und klinische Relevanz: Das optimierte Testreagens erlaubt im Vergleich zu dem kommerziell verfügbaren Reagens die frühzeitige Erkennung zellzahlhoher Viertel bzw. Tiere. Die Ergebnisse machten deutlich, dass das Ablesen des Testresultats direkt nach der Reaktion erfolgen muss.
Collapse
|
39
|
Paduch JH, Herold M, Krömker V. [Diagnostic characteristics of a new California Mastitis Test]. Tierarztl Prax Ausg G Grosstiere Nutztiere 2013; 41:81-87. [PMID: 23608888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2012] [Accepted: 01/14/2013] [Indexed: 06/02/2023]
Abstract
OBJECTIVE For the early detection of udder health disorders in praxi, it is necessary to use a method with high sensitivity. The aim of the present study was to investigate the sensitivity of a commercial Califor- nia Mastitis Test and a new reagent which was optimised for the detection of udder health disorders with somatic cell counts > 100,000 cells/ml. MATERIAL AND METHODS The viscosity of mixtures of test milks with standardised somatic cell counts (50,000-800,000 cells/ml) and test reagents were analysed in vitro. A total of 50 quarter fore- milk samples from cows without signs of clinical mastitis were investigated using both California Mastitis Test reagents. Sensitivity and specificity were calculated. RESULTS The viscosity of mixtures increased with a higher somatic cell count. At a somatic cell count of 50,000 cells/ml, the mean viscosities were 3.20 mPa*s (commer- cial product) and 2.69 mPa*s (optimised reagent). At a somatic cell count of 100,000 cells/ml the viscosities increased to 3.43 mPa*s and 4.58 mPa*s, respectively. At a somatic cell count threshold of 100,000 cells/ml, marking the transition of the physiological status into a secretion disorder, the sensitivity of the commercial test was 76.7% and that of the optimised test was 97.7%. CONCLUSION AND CLINICAL RELEVANCE The optimised California Mastitis Test allows - compared to the commercial product - the early detection of quarters or animals with high somatic cell counts. The results of the study indicate that the test result has to be evaluated immediately after the California Mastitis Test reaction.
Collapse
Affiliation(s)
- J-H Paduch
- Fakultät II, Abteilung Bioverfahrenstechnik, Hochschule Hannover
| | | | | |
Collapse
|
40
|
Kamp H, Strauss V, Wiemer J, Leibold E, Walk T, Mellert W, Looser R, Prokoudine A, Fabian E, Krennrich G, Herold M, van Ravenzwaay B. Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies. Toxicol Lett 2012; 215:143-9. [DOI: 10.1016/j.toxlet.2012.09.015] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2012] [Revised: 09/18/2012] [Accepted: 09/24/2012] [Indexed: 11/28/2022]
|
41
|
Strauss V, Mellert W, Wiemer J, Leibold E, Kamp H, Walk T, Looser R, Prokoudine A, Fabian E, Krennrich G, Herold M, van Ravenzwaay B. Increased toxicity when fibrates and statins are administered in combination – A metabolomics approach with rats. Toxicol Lett 2012; 211:187-200. [DOI: 10.1016/j.toxlet.2012.03.798] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2011] [Revised: 03/19/2012] [Accepted: 03/21/2012] [Indexed: 10/28/2022]
|
42
|
Santarpino G, Pfeiffer S, Herold M, Fischlein T. Sutureless aortic valve prosthesis: A fast option for a mini-invasive approach. Thorac Cardiovasc Surg 2012. [DOI: 10.1055/s-0031-1297602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
43
|
Abstract
The most common manifestation of plasma cell neoplasms is multiple myeloma. Solitary and localized tumours in the form of solitary plasmacytoma of the bone or extramedullary plasmacytoma are rare. In the late stages of multiple myeloma, bulky bone tumour infiltrates may be found which may be the primary clinical manifestation of the previously unknown malignancy. We report a case of a hyoid bone tumour with extramedullary plasma cell infiltrates in the oropharynx in multiple myeloma.
Collapse
Affiliation(s)
- V Sychra
- Institute of Diagnostic and Interventional Radiology and Neuroradiology, Erfurt. Germany.
| | | | | | | |
Collapse
|
44
|
Mellert W, Kapp M, Strauss V, Wiemer J, Kamp H, Walk T, Looser R, Prokoudine A, Fabian E, Krennrich G, Herold M, van Ravenzwaay B. Nutritional impact on the plasma metabolome of rats. Toxicol Lett 2011; 207:173-81. [PMID: 21907771 DOI: 10.1016/j.toxlet.2011.08.013] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2011] [Revised: 08/16/2011] [Accepted: 08/18/2011] [Indexed: 10/17/2022]
Abstract
Metabolite profiling (metabolomics) elucidates changes in biochemical pathways under various conditions, e.g., different nutrition scenarios or compound administration. BASF and metanomics have obtained plasma metabolic profiles of approximately 500 compounds (agrochemicals, chemicals and pharmaceuticals) from 28-day rat studies. With these profiles the establishment of a database (MetaMap(®)Tox) containing specific metabolic patterns associated with many toxicological modes of action was achieved. To evaluate confounding factors influencing metabolome patterns, the effect of fasting vs. non-fasting prior to blood sampling, the influence of high caloric diet and caloric restriction as well as the administration of corn oil and olive oil was studied for its influence on the metabolome. All mentioned treatments had distinct effects: triacylglycerol, phospholipids and their degradation product levels (fatty acids, glycerol, lysophosphatidylcholine) were often altered depending on the nutritional status. Also some amino acid and related compounds were changed. Some metabolites derived from food (e.g. alpha-tocopherol, ascorbic acid, beta-sitosterol, campesterol) were biomarkers related to food consumption, whereas others indicated a changed energy metabolism (e.g. hydroxybutyrate, pyruvate). Strikingly, there was a profound difference in the metabolite responses to diet restriction in male and female rats. Consequently, when evaluating the metabolic profile of a compound, the effect of nutritional status should be taken into account.
Collapse
Affiliation(s)
- W Mellert
- BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Kamp H, Herold M, Fabian E, Looser R, Krenrich G, Mellert W, Prokoudine A, Strauss V. Metabolomics in vivo as a tool for chemical grouping under reach. Toxicol Lett 2011. [DOI: 10.1016/j.toxlet.2011.05.735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
46
|
Niederwieser D, Maschmeyer G, Fischer T, Uharek L, Kortmann R, Hegenbart U, Dreger P, Herold M, Sayer HG, Wolf H, Kreibich U, Hähling D, Junghanss C, Grobe N, Krahl R, Lange T, Al-Ali HK, Pönisch W, Nehring C, Doelken G. Relapse incidence and leukemia-free survival (LFS) in patients (pts) older than age 60 with AM undergoing stem cell transplantation: A report of the East German Study Group Hematology and Oncology (OSHO). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.6523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
47
|
Lange T, Niederwieser D, Hoffmann V, Pfirrmann M, Maschmeyer G, Fischer T, Herold M, Sayer HG, Junghanss C, Krahl R, Al-Ali HK, Pönisch W, Vucinic V, Doelken G, Sauerland MC, Heinecke A, Hoelzer D, Hehlmann R, Berdel WE, Buchner T. Intergroup study in elderly patients with AML to compare complete remission rate and overall survival after intermediate-dose or low-dose AraC. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.6618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
48
|
Buchhold R, Nakladal A, Gerlach G, Sahre K, Eichhorn KJ, Herold M, Gauglitz G. Influence of Moisture-Uptake on Mechanical Properties of Polymers Used in Microelectronics. ACTA ACUST UNITED AC 2011. [DOI: 10.1557/proc-511-359] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
ABSTRACTPolymers are currently considered as a possible alternative to silicon dioxide in the fabrication of interlevel dielectrics. To penetrate mainstream semiconductor device fabrication polymers have to meet a number of requirements regarding their long-term stability. One aspect is the mechanical stability of integrated polymer films under changing climatic conditions. In the present work, the impact of ambient moisture on the mechanical properties of thin polymer films (PI, BCB, and PFCB) was investigated. The sorption of water molecules in these materials typically causes an anisotropic volume expansion, resulting in increased mechanical film stress if the film is physically constrained by adjacent inorganic structures. Especially polyimides show both considerable moisture uptake and large changes in the mechanical film stress, while BCB and PFCB are virtually insensitive to ambient moisture. In the paper, experimental data (water uptake, in-plane swelling, out-of-plane swelling) are presented and discussed in detail.
Collapse
|
49
|
|
50
|
Strasser A, Bouillet P, Adams JM, Kelly PN, Kelly G, Herold M, Glaser S, Robb L, O'Reilly LA, Delbridge A, Grabow S, Scott CL, Cory S, Adams JM. The many roles of apoptotic cell death in the immune system (LL3-6). Int Immunol 2010. [DOI: 10.1093/intimm/dxq207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|